IC
IDF CAPITAL
Private EquityActiveFounded in 1995, the IDF Capital (formerly Development IDF) has passed the 185 supported and positioned itself as a major venture capital
16
Investments
4
Exits
—
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for IDF CAPITAL.
Investment Thesis & Strategy
IDF Capital is a private equity firm that invests in various stages of fintech companies, leveraging its extensive experience since 1995 to support and scale promising ventures in the financial technology sector.
Investment Activity
Deals per year over the last 19 years
1
20000
20010
20020
20030
20040
20050
20060
20070
20080
20093
20100
20112
20121
20131
20141
20150
20160
20171
2018Portfolio Companies
Selected investments from their portfolio of 16 companies
E
Euronovia
Biotech · Series A, 2018
B
Bone Therapeutics
Biotech · Series C+, 2015
P
Pixium Vision
Biotech · Series C+, 2014
A
Abivax
Biotech · Series C+, 2013
D
DBV Technologies
Biotech · Series C+, 2012
N
Nanobiotix
Biotech · Series C+, 2012
T
Theraclion
Healthcare · Series C+, 2010
C
Carmat
Biotech · Series C+, 2010
V
Vexim
Healthcare · Series C+, 2010
I
Innate Pharma
Biotech · Series C+, 2000
Frequently Asked Questions
IDF CAPITAL focuses on Series B, Series C+ stage investments.